Results 241 to 250 of about 259,118 (384)

Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]

open access: yes, 2016
Atkins   +46 more
core   +2 more sources

Investigation and future trend prediction of disease burden of chronic kidney disease due to diabetes mellitus type 2 globally and in China from 1990 to 2021

open access: yesJournal of Diabetes Investigation, EarlyView.
This study focuses on the disease burden of chronic kidney disease due to type 2 diabetes (CKD due to type 2 diabetes) globally and in China from 1990 to 2021 and predicts its trend from 2022 to 2031. ABSTRACT Objective To analyze the disease burden of chronic kidney disease due to diabetes mellitus type 2 (CKD due to diabetes mellitus type 2) in China
Jinpeng Du   +5 more
wiley   +1 more source

Linderalactone mitigates diabetic renal injury by inhibiting macrophage inflammation via the Dectin1/Syk/CARD9/IRF5/NF‐κB pathway

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Background Inflammation plays an essential role in the pathogenesis of diabetic nephropathy (DN). Linderalactone (LNL), as a natural sesquiterpene lactone, has been discovered to have anti‐inflammatory activation. However, the effects of linderalactone on diabetes‐associated renal damage remain unclear.
Hao Chen   +7 more
wiley   +1 more source

The biology of PKM2 in the metabolism and senescence in diabetic kidney disease

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Diabetic kidney disease (DKD) is one of the most common causes of chronic kidney disease that leads to end‐stage kidney disease, and its progression is closely linked to metabolic stress within renal tubular cells. Under long‐term hyperglycemia, cells shift their glucose metabolism from normal oxidative phosphorylation toward glycolysis.
Md. Imrul Kayes, Keizo Kanasaki
wiley   +1 more source

Home - About - Disclaimer - Privacy